Location via proxy:
[ UP ]
[Report a bug]
[Manage cookies]
No cookies
No scripts
No ads
No referrer
Show this form
Home
News
Tech
Finance
Leadership
Well
Recommends
Fortune 500
Home Page
Already have an account?
SIGN IN
SEARCH
Subscribe Now
Sections
FORTUNE 500
News
Europe
Asia
Tech
AI
Finance
Personal Finance
Real Estate
Crypto
Leadership
Success
Well
Life
Health
Mind
Family
Aging Well
Recommends
Credit Cards
Banking
Best High-Yield Savings Accounts
Best Savings Accounts
Best CD Rates
Best Money Market Accounts
Savings Calculator
Insurance
Mortgages
Investing
Loans
Health
Education
Top Business Schools
Top Information Technology and Data Schools
Top Health Schools
Business Solutions
Video
Rankings
FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS
Fortune Company List
Analytics
Newsletters
Magazine
December 2023/January 2024
October/November 2023
August/September 2023
June/July 2023
April/May 2023
February/March 2023
Live Media
CEO Initiative
Steven Tian
Commentary
We led some of America’s largest companies. Here’s why we are voting for Harris, not Trump
BY
Doug Parker
,
Reid Hoffman
, and others
Commentary
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Biden-Harris have a track record of real success in bringing manufacturing back to America. Trump’s all-sticks-no-carrots approach already failed
BY
Jeffrey Sonnenfeld
,
Laura Tyson
, and others
Commentary
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
After 2 years of peddling Putin’s propaganda, the IMF is returning to Russia in open defiance of the West
BY
Jeffrey Sonnenfeld
,
Tymofiy Mylovanov
, and others
Commentary
Brian Niccol may well be the messiah Starbucks—and Howard Schultz—have been looking for
BY
Jeffrey Sonnenfeld
,
Stephen Henriques
, and others
Commentary
The WSJ’s Evan Gershkovich had his employer’s support—but that’s not always the case for employees on an overseas mission
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
The ‘Trump Dump’ is back—and the stocks that he targets are crashing
BY
Jeffrey Sonnenfeld
,
Whitney Tilson
, and others
Commentary
200 top CEOs reveal how AI is already transforming their sectors at Yale summit
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Activist investors are suffering grueling defeats in proxy fights—but they can still matter when they pick the right battle
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Norfolk Southern is getting back on track–but activist investor Ancora is trying to derail it in a vicious proxy fight
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Why Bob Iger’s strategy for the next decade of growth at Disney promises a magic carpet ride for the Magic Kingdom’s future
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Inside the cockpit at Boeing: Here are the top 5 candidates for CEO as Dave Calhoun exits
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
The latest sanctions on Russia won’t be sufficient. Here’s what would be, according to the Yale professor who inspired the great business exodus over Ukraine
BY
Jeffrey Sonnenfeld
and
Steven Tian
Commentary
Nelson Peltz is America’s most overrated activist investor. Here’s what the experts missed about his performance
BY
Jeffrey Sonnenfeld
and
Steven Tian
Load More